规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | SGK1 (glucocorticoid-regulated kinase 1) belongs to the AGC family of serine/threonine protein kinases. SGK1 expression is regulated by glucocorticoids and serum, in addition to various other types of signals. SGK1 has been implicated in the regulation of cell growth and survival downstream of PI3K activation. GSK650394 inhibites the enzymatic activity of SGK1 and SGK2 in the SPA assay with IC50 values of 62 nM and 103 nM, respectively. GSK650394 is relatively non-toxic, with LC50 values of 41 μM in M1 cells and a LC50 greater than 100 μM in HeLa cells in XTT assays. Moreover, GSK650394 inhibits SGK1-mediated epithelial transport with an IC50 of 0.6 μM in the SCC assay. In the LNCaP growth assay, the IC50 of GSK650394 was approximately 1 μM. Furthermore, 10 μM of GSK650394 completely abrogated androgen-mediated growth, indicating that GSK650394 may be an effective approach for the treatment of AR (androgen receptor)-driven prostate cancer [3]. GSK-650394 (1, 10, and 30 μM, 10 μL/rat, intrathecally) dose-dependently prevented CFA (complete Freund's adjuvant)-induced pain behavior and the associated SGK1 phosphorylation, GluR1 trafficking, and protein-protein interactions at 1 day after CFA administration [4]. Daily GSK-650394 administration (from day 0 to 6 postsurgery; 100 nm, 10 μl, i.t.) alleviated SNL-induced allodynia at days 3, 5, and 7 postsurgery compared with animals that received no injection [5]. |
Concentration | Treated Time | Description | References | |
A549 cells | 0.78 to 100 µM | 24, 48, 72, 96 hours | To test the effect of GSK 650394 on the viability of A549 cells. The results showed that cells maintained good viability (≥91%) at 0.78 to 3.13 µM throughout the 96-hour period, at 6.25 to 50 µM up to 48 h (≥75%), and had poor viability (≤64%) at 100 µM. | J Virol. 2013 May;87(10):6020-6. |
Administration | Dosage | Frequency | Description | References | ||
Sprague-Dawley rats | Neuropathic pain model | Intrathecal injection | 100 nM | Once daily for 7 days | GSK-650394 alleviated neuropathic pain behaviors, reduced pSGK1–kalirin costaining, and attenuated SGK1–kalirin coupling. | J Neurosci. 2013 Mar 20;33(12):5227-40 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.61mL 0.52mL 0.26mL |
13.07mL 2.61mL 1.31mL |
26.15mL 5.23mL 2.61mL |
CAS号 | 890842-28-1 |
分子式 | C25H22N2O2 |
分子量 | 382.45 |
SMILES Code | O=C(O)C1=CC=C(C2=CNC3=NC=C(C4=CC=CC=C4)C=C32)C=C1C5CCCC5 |
MDL No. | MFCD12828779 |
别名 | |
运输 | 蓝冰 |
InChI Key | WVSBGSNVCDAMCF-UHFFFAOYSA-N |
Pubchem ID | 25022668 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 40 mg/mL(104.59 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|